Trastuzumab BS IV infusion 150mg “CTH” is a biosimilar of trastuzumab (genetical recombination), manufactured by Celltrion. This injectable drug (YJ code: 4291442D2021) is supplied as 150mg per bottle and is used to treat certain types of breast cancer and metastatic gastric cancer.
Trastuzumab BS IV infusion 150mg “CTH”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →